1 / 10

Synapse and Catapult– New NIH OTT Technology Transfer Tools

Synapse and Catapult– New NIH OTT Technology Transfer Tools. Ajoy K. Prabhu, M.S., M.B.A. Group Leader, Marketing Office of Technology Transfer National Institutes of Health U.S. Department of Health & Human Services. Federal Lab Consortium Mid-Atlantic Regional Meeting October 22, 2007.

kass
Télécharger la présentation

Synapse and Catapult– New NIH OTT Technology Transfer Tools

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Synapse and Catapult– New NIH OTT Technology Transfer Tools Ajoy K. Prabhu, M.S., M.B.A. Group Leader, Marketing Office of Technology Transfer National Institutes of Health U.S. Department of Health & Human Services Federal Lab ConsortiumMid-Atlantic Regional Meeting October 22, 2007

  2. New Inventions NIH OTT Technologies Available for Licensing Brand Awareness & Networking Infectious Diseases & Medical Devices Cancer General Medicine Marketing Group Tech. Transfer Service Center

  3. NIH OTT Technologies Available for Licensing Brand Awareness & Networking Infectious Diseases & Medical Devices Cancer General Medicine Marketing Group Tech. Transfer Service Center New Inventions

  4. Synapse Companies NIH OTT Technologies Available for Licensing

  5. SynapseSM 5

  6. SynapseSMBenefits SynapseSM has made it possible for OTT to reach a wider business market by matching its portfolio to the research interests of biotechnology and pharmaceutical companies. OTT is able to proactively market and provide individualized and targeted information to companies that were unaware of the scientific possibilities available to them at NIH and FDA. SynapseSMcan also be used to address other research and development challenges, including patent prosecution and enforcement, searching for experts, and portfolio management. 6

  7. Data Sources • SynapseSMdraws from several databases: • TechTracS®, the internal database containing NIH and FDA intramural research portfolios • U.S. Patent and Trademark Office (USPTO) patent applications and issued patents • CRISP (Computer Retrieval of Information on Scientific Projects), the database of millions of records of HHS/NIH funded biomedical research projects conducted at universities, hospitals, and other research institutions. • RaDiUS® (Research and Development in the United States), a database maintained by the RAND Corp. that includes all research grants and contracts awarded by federal agencies • Medline®, a database containing abstracts or full text of 16 million articles published in nearly 5000 journals • Millions of records of biomedical news stories. The data are transformed and stored to allow for seamless—and rapid—cross-linking between databases. 7

  8. SynapseSM– Current Uses • Analyze ~7,000 NIH IP for licensing • Help find licensing partners • Search IP for VCs and Angel Investors • Search USPTO for NIH-complimentary IP • Extramural grantees  intramural IP 8

  9. Synapse Demonstration Synapse Dem

  10. For further information http://www.ott.nih.gov Science. Ideas. Breakthroughs.

More Related